NCPA attends signing of bipartisan opioid relief package
WASHINGTON – As President Trump signs H.R. 6, the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, several National Community Pharmacists Association-supported provisions contained in the opioid package become law. NCPA chief executive officer B. Douglas Hoey and Karry La Violette, NCPA’s senior vice president of government affairs and director
